Projects per year
Fingerprint
Dive into the research topics where Marina Konopleva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 15 Finished
-
Defining the novel cancer testis antigen HSPA1L as immunotherapeutic target in AML
Konopleva, M. (PI)
5/20/22 → 3/31/23
Project: Research project
-
Inhibition of Bcl-xL by Targeted Degradation
Zheng, G. (PI), Zhou, D. (CoPI) & Konopleva, M. (CoPI)
4/1/20 → 3/31/25
Project: Research project
-
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
Konopleva, M. M. Y. (PI), Spencer, D. D. H. (CoPI), Konopleva, M. (CoPI) & Welch, J. S. (CoPI)
6/17/19 → 5/31/25
Project: Research project
-
Targeting mitochondrial complex I in acute lymphoblastic leukemia
Konopleva, M. (PI) & Konopleva, M. M. Y. (CoPI)
6/14/19 → 5/31/25
Project: Research project
-
Career Enhancement Program
Konopleva, M. (PI), Konopleva, M. M. Y. (PI) & Kantarjian, H. (PI)
9/1/18 → 8/31/23
Project: Research project
-
A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion
Majid, D., Wang, Z., Schalk, A. M., Yuan, B., Tatarata, Q. Z., Root, J. L., Garza, A. I., Yassouf, M. Y., Gamal, B. T., Feri-Borgogno, S., Nguyen, A. H., Konopleva, M., Peeters, E., Su, Y., Reville, P. K., Ravandi-Kashani, F., Lavie, A. & Abbas, H. A., 2026, In: Frontiers in Oncology. 15, 1606239.Research output: Contribution to journal › Article › peer-review
Open Access -
Analysis of Patients With Monocytic and Monocytic-Like Acute Myeloid Leukemia, Including AML-M4 and AML-M5, Treated With Venetoclax Plus Azacitidine
Konopleva, M., DiNardo, C. D., Sun, Y., Jung, P., Loghavi, S., Potluri, J., Dail, M., Chyla, B. & Pollyea, D. A., Mar 2026, In: American Journal of Hematology. 101, 3, p. 577-580 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access3 Link opens in a new tab Scopus citations -
A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia
Konopleva, M., Bhatt, V. R., Mantzaris, I., Maiti, A., Gundabolu, K., Schafer, J., Jensen, K., Saleem, R., Li, Y., Drewniak, A., Bay, P., Huh, W., Yildirim, O., Abbadessa, G., Cooley, S. & Daver, N., May 2026, In: Cancer Immunology, Immunotherapy. 75, 5, 143.Research output: Contribution to journal › Article › peer-review
Open Access -
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia
Chakraborty, S., Morganti, C., Zaldana, K., Rivera Pena, B., Zhang, H., Verma, D., Gitego, N., Ma, F., Aluri, S., Pradhan, K., Gordon-Mitchell, S., Mantzaris, I., Goldfinger, M., Feldman, E., Gritsman, K., Shi, Y., Hubner, S., Qiu, Y. H., Brown, B. D. & Khasawneh, A. & 13 others, , Apr 2026, In: Leukemia. 40, 4, p. 717-729 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Correction: TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches (Frontiers in Oncology, (2026), 16, (1735418), 10.3389/fonc.2026.1735418)
Deshpande, S., Li, W. F., Song, J., Forsberg, M., Cerchione, C., Martinelli, G. & Konopleva, M., 2026, In: Frontiers in Oncology. 16, 1823072.Research output: Contribution to journal › Comment/debate › peer-review
Open Access